Patent Term Extension Application for AWIQLI® (insulin icodec-abae), Patent No. 9,045,560 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2026-E-8226

Patent Term Extension Application for AWIQLI® (insulin icodec-abae), Patent No. 9,045,560

Documents

Comments

Description

OPEN

Comment Period OpensJul 30, 2026

Type	Title	Posted	Comments	Status
Other	Letter from U. S. Patent and Trademark Office to FDA CDER	Jul 30, 2026	--

CDER

Patent Term Extension Application for AWIQLI®

Novo Nordisk Inc.

Novo Nordisk A/S

(insulin icodec-abae)

Patent No. 9,045,560

OPEN